09/03/2018
https://www.congress.gov...
"The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medicines into the marketplace."
"I think they harm drug competition."
"We should be doing all we can to see that the American consumer has access to lower-priced drugs."
"According to the 2010 Federal Trade Commission report entitled 'Pay For Delay: How Drug Companies Payoffs Cost Consumers Billions,' these settlements cost consumers approximately $35 billion over 10 y..."